Advertisement
HealthDay Reports: Why Is Coronavirus a Bigger Worry for People With Diabetes?

Early Anticoagulation May Not Up Survival in Severe COVID-19

0

Venous thromboembolism seen in 6.3 percent and major bleeding seen in 2.8 percent of critically ill COVID-19 patients

Drug Makers Raise Prices on 500 Prescription Drugs

U.S. Drug Prices 256 Percent Higher Than in 32 OECD Countries

0

U.S. prices higher than those in comparison countries for brand-name originator drugs, but lower for unbranded generics

ACG: Resilience-Based Care Coordination Program Benefits IBD

Crohn Disease, Comorbidities Up Risk for Severe Pneumococcal Disease

0

Receipt of PCV13 alone or in combination with PPSV23 predicts fivefold reduced risk for SPD compared with no vaccination

Biden Outlines 'Bold' National Vaccine Effort

Biden Signs Orders to Expand Health Care Access

0

Reopened Affordable Care Act health insurance enrollment period will run from Feb. 15 to May 15

More Dangerous Mouthwashes and Hand Sanitizers Recalled

FDA: All Alcohol-Based Hand Sanitizers From Mexico on ‘Import Alert’

0

Large number of hand sanitizers from Mexico have tested positive for methanol contamination

Dexamethasone Not Favored for Chronic Subdural Hematoma

Metformin Use for T2DM May Reduce COVID-19 Mortality

0

Odds of contracting COVID-19, COVID-19-related mortality higher for individuals with diabetes

Many Adults Do Not See Link Between Racism, Poorer Health

0

Findings revealed in national survey of U.S. adults with family incomes of less than $125,000

Aspirin Use Tied to Longer Bladder, Breast Cancer Survival

0

However, aspirin use in older adults not tied to incidence of various cancer types

La vacuna de Pfizer contra la COVID parece promisoria

COVID-19 Antibody Treatments Exceed Expectations in Early Trials

0

Eli Lilly and Regeneron asking regulators to expand authorization of their drugs based on the new findings

Metformin Recalled Due to Contamination With Carcinogen

Adverse Drug Reactions Linked to Hydroxychloroquine Up in 2020

0

ADRs associated with hydroxychloroquine, chloroquine more than doubled in 2020 versus 2018 and 2019